| Iodine-131-labeled Meta-Iodobenzylguanidine Therapy of Children with Neuroblastoma: Program Planning and Initial Experience. | |
| | |
MedLine Citation:
|
PMID: 21803185 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Patients with high-risk neuroblastoma have a poor prognosis, especially in cases of recurrent or relapsed disease. Iodine-131-labeled meta-iodobenzylguanidine ((131)I-MIBG) can be an effective and relatively well-tolerated agent for the treatment of refractory neuroblastoma. Establishing an MIBG therapy program requires a great deal of planning, availability of hospital resources, and the commitment of individuals with training and expertise in multiple disciplines. Providing (131)I-MIBG therapy requires physical facilities and procedures that permit patient care in compliance with the standards for occupational and community exposure to radiation. Establishment of a successful (131)I-MIBG therapy program also requires a detailed operational plan and appropriate education for caregivers, parents, and patients. |
| | |
Authors:
|
Suzanne Shusterman; Frederick D Grant; William Lorenzen; Royal T Davis; Stephen Laffin; Laura A Drubach; Frederic H Fahey; S Ted Treves |
Related Documents
:
|
11011545 - Comparison of service member and military spouse satisfaction with installation fitness... 19363775 - Using organizational collaboration and community partnerships to transition families fr... 15943135 - More than just being there: balancing the participation equation. 8038635 - Educating physicians about women's health. survey of canadian family medicine residency... 10977375 - Sun-safe behaviour among secondary school students in australia. 22465375 - Life goal appraisal and marijuana use among college students. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Seminars in nuclear medicine Volume: 41 ISSN: 1558-4623 ISO Abbreviation: Semin Nucl Med Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-08-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1264464 Medline TA: Semin Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 354-63 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Pediatric Oncology, Dana-Farber Cancer Center, Boston, MA; Division of Hematology/Oncology, Department of Medicine, Children's Hospital Boston, Boston, MA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pediatrics: diagnosis of neuroblastoma.
Next Document: Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid c...